Oct 29, 2016 - duPont Hospital for Children, Wilmington, Delaware; 2Department of Pediatrics,. Division of Infectious Diseases, The Children's Hospital of ...
1933. Comparative Effectiveness Of Intravenous Versus Oral Antibiotics for Post-Discharge Treatment of Perforated Appendicitis in Children Lori Handy, MD1; Rana F. Hamdy, MD, MPH2; Matthew Bryan, PhD3; Daniele Dona, MD2; Evangelos Spyridakis, MD4; Areti Kyriakousi, PhD4; Talene A. Metjian, PharmD5; Jeffrey S. Gerber, MD, PhD2; 1Division of Infectious Diseases, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware; 2Department of Pediatrics, Division of Infectious Diseases, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; 3Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; 4Division of Infectious Diseases, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania; 5Antimicrobial Stewardship Program, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Session: 225. Antibiotic Stewardship: Pediatrics Saturday, October 29, 2016: 12:30 PM Background. Acute appendicitis is one of the most common emergent surgical conditions in pediatrics and can be complicated by perforation. Limited data are available to guide clinicians in both the route and spectrum of antibiotic therapy required for the treatment of perforated appendicitis in children after discharge.
Methods. Retrospective cohort study comparing outcomes following post-discharge intravenous (IV) or oral therapy for perforated appendicitis at a large, tertiary care children’s hospital. Patients 48 hours prior to surgery, or appendicitis without acute perforation were excluded. Treatment failure was defined as abscess or wound infection. Secondary complications included central venous catheter complications, medication adverse effects, or ongoing abdominal symptoms that were not infectious. Results. Of 838 children with perforated appendicitis, 782 were prescribed antibiotic therapy at hospital discharge; 203 received IV antibiotics, range 0–75% across 26 surgeons (Figure 1) while 579 received oral antibiotics. Treatment failure occurred in 27 (4.7%) children receiving oral and 6 (3.0%) receiving IV therapy, and secondary complications occurred in 16 (2.8%) children receiving oral and 37 (18.2%) receiving IV therapy. In a multivariable logistic regression model adjusted for sex, age, length of stay, race, initial white blood cell count, C-reactive protein, creatinine, parenteral nutrition, inpatient complications, and inclusion of an anti-pseudomonal agent at discharge, treatment failure was not significantly associated with use of with IV antibiotics (aOR 0.22; 95% CI 0.04–1.35) but was associated with secondary complications (aOR 5.16; 95% CI 1.94–13.68). Conclusion. In children with perforated appendicitis, treatment failure did not differ between children treated with IV versus oral antibiotics after discharge. However, secondary complications were significantly increased in patients with IV therapy after discharge. Disclosures. All authors: No reported disclosures
Poster Abstracts
•
OFID 2016:3 (Suppl 1)
•
S515
